HUP0105116A3 - 2,3-0-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors, pharmaceutical compositions containing them, process for preparation of the compounds - Google Patents
2,3-0-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors, pharmaceutical compositions containing them, process for preparation of the compoundsInfo
- Publication number
- HUP0105116A3 HUP0105116A3 HU0105116A HUP0105116A HUP0105116A3 HU P0105116 A3 HUP0105116 A3 HU P0105116A3 HU 0105116 A HU0105116 A HU 0105116A HU P0105116 A HUP0105116 A HU P0105116A HU P0105116 A3 HUP0105116 A3 HU P0105116A3
- Authority
- HU
- Hungary
- Prior art keywords
- monosaccharides
- compounds
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
- C07H9/04—Cyclic acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN86DE1999 IN190975B (enExample) | 1999-01-15 | 1999-01-15 | |
| US09/276,368 US6590085B1 (en) | 1999-01-15 | 1999-03-25 | Derivatives of monosaccharides as cell adhesion inhibitors |
| PCT/IB2000/000022 WO2000042054A1 (en) | 1999-01-15 | 2000-01-10 | 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0105116A2 HUP0105116A2 (hu) | 2003-04-28 |
| HUP0105116A3 true HUP0105116A3 (en) | 2003-05-28 |
Family
ID=11088155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0105116A HUP0105116A3 (en) | 1999-01-15 | 2000-01-10 | 2,3-0-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors, pharmaceutical compositions containing them, process for preparation of the compounds |
Country Status (30)
| Country | Link |
|---|---|
| US (5) | US6590085B1 (enExample) |
| EP (1) | EP1147119B1 (enExample) |
| JP (1) | JP2002534530A (enExample) |
| CN (1) | CN1167707C (enExample) |
| AR (1) | AR022235A1 (enExample) |
| AT (1) | ATE250074T1 (enExample) |
| AU (1) | AU768511B2 (enExample) |
| BG (1) | BG105745A (enExample) |
| BR (1) | BR0007553A (enExample) |
| CA (1) | CA2359986A1 (enExample) |
| CO (1) | CO5180591A1 (enExample) |
| CR (1) | CR6423A (enExample) |
| CZ (1) | CZ20012540A3 (enExample) |
| DE (1) | DE60005300T2 (enExample) |
| DK (1) | DK1147119T3 (enExample) |
| ES (1) | ES2206176T3 (enExample) |
| HR (1) | HRP20010529B1 (enExample) |
| HU (1) | HUP0105116A3 (enExample) |
| ID (1) | ID30351A (enExample) |
| IN (1) | IN190975B (enExample) |
| MA (1) | MA25342A1 (enExample) |
| MX (1) | MXPA01007187A (enExample) |
| MY (1) | MY121135A (enExample) |
| NZ (2) | NZ527483A (enExample) |
| PA (1) | PA8489901A1 (enExample) |
| PT (1) | PT1147119E (enExample) |
| SK (1) | SK284241B6 (enExample) |
| TR (1) | TR200102043T2 (enExample) |
| WO (1) | WO2000042054A1 (enExample) |
| YU (1) | YU50701A (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN190975B (enExample) * | 1999-01-15 | 2003-09-06 | Ranbaxy Lab Ltd | |
| NZ577031A (en) | 2003-05-30 | 2010-09-30 | Ranbaxy Lab Ltd | Substituted pyrrole derivatives and their use as HMG-CO inhibitors |
| WO2006024926A1 (en) * | 2004-09-02 | 2006-03-09 | Ranbaxy Laboratories Limited | Monosaccharide derivatives |
| US20100113371A9 (en) * | 2004-12-22 | 2010-05-06 | Ranbaxy Laboratories Limited Inc. | Derivatives Of Pentose Monosaccharides As Anti-Inflammatory Compounds |
| US20090054519A1 (en) * | 2005-07-22 | 2009-02-26 | Abhijit Ray | Derivatives of monosaccharides as 5-lipoxygenase inhibitors |
| WO2007054896A1 (en) * | 2005-11-08 | 2007-05-18 | Ranbaxy Laboratories Limited | Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt |
| TW200744583A (en) * | 2006-03-14 | 2007-12-16 | Ranbaxy Lab Ltd | Statin stabilizing dosage formulations |
| EP1842855A3 (en) * | 2006-03-29 | 2007-12-05 | Ranbaxy Laboratories Limited | Monosaccharide derivatives as anti-inflammatory and/or anti-cancer agents |
| US7790689B2 (en) * | 2006-05-30 | 2010-09-07 | Ranbaxy Laboratories Limited | Monosaccharide derivatives |
| EP1953170A1 (en) * | 2006-10-03 | 2008-08-06 | Ranbaxy Laboratories Limited | Monosaccharide derivatives as anti-inflammatory agents |
| AU2008221506B2 (en) * | 2007-09-20 | 2011-01-20 | ResMed Pty Ltd | Retractable Tube for CPAP |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2715121A (en) | 1950-09-09 | 1955-08-09 | American Home Prod | Alkyl sugar derivatives and their preparation |
| US4056322A (en) | 1973-12-14 | 1977-11-01 | Strategic Medical Research Corporation | Preparation of ethers of monosaccharides |
| US4735934A (en) | 1981-02-17 | 1988-04-05 | Greenwich Pharmaceuticals Incorporated | Method of therapeutically treating a warm blooded animal afflicted with an autoimmune disease |
| US4996195A (en) | 1989-01-09 | 1991-02-26 | Greenwich Pharmaceuticals Inc. | Derivatives of α,D-glucofuranose or α,D-allofuranose and intermediates for preparing these derivatives |
| US5010058A (en) | 1989-06-22 | 1991-04-23 | 501 Greenwich Pharmaceuticals Incorporated | 3,5,6-substituted derivatives of 1,2-O-isopropylidene-α,D-glucofuranose and intermediates for preparing these derivatives |
| FR2652540B1 (fr) | 1989-10-02 | 1995-06-02 | Imaje Sa | Circuit d'encre notamment destine a la mise en pression d'une encre a pigments pour imprimante a jet d'encre. |
| US5192746A (en) | 1990-07-09 | 1993-03-09 | Tanabe Seiyaku Co., Ltd. | Cyclic cell adhesion modulation compounds |
| US5258402A (en) | 1992-06-11 | 1993-11-02 | Mcneil-Ppc, Inc. | Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates |
| US5432163A (en) | 1992-11-13 | 1995-07-11 | Greenwich Pharmaceuticals Incorporated | Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides |
| US5637570A (en) * | 1995-05-09 | 1997-06-10 | Chemora Pharmochem | Disubstituted and trisubstituted derivatives of 2,3:4,6-di-O-isopropylidene-α-L-xylo-2-hexulofuranosonic acid having anti-cancer, anti-inflammatory and anti-proliferative activity |
| IN190975B (enExample) * | 1999-01-15 | 2003-09-06 | Ranbaxy Lab Ltd |
-
1999
- 1999-01-15 IN IN86DE1999 patent/IN190975B/en unknown
- 1999-03-25 US US09/276,368 patent/US6590085B1/en not_active Expired - Fee Related
-
2000
- 2000-01-10 HU HU0105116A patent/HUP0105116A3/hu unknown
- 2000-01-10 AR ARP000100086A patent/AR022235A1/es not_active Application Discontinuation
- 2000-01-10 SK SK10132001A patent/SK284241B6/sk unknown
- 2000-01-10 WO PCT/IB2000/000022 patent/WO2000042054A1/en not_active Ceased
- 2000-01-10 AU AU18861/00A patent/AU768511B2/en not_active Ceased
- 2000-01-10 CN CNB008048525A patent/CN1167707C/zh not_active Expired - Fee Related
- 2000-01-10 ES ES00900088T patent/ES2206176T3/es not_active Expired - Lifetime
- 2000-01-10 ID IDW00200101520A patent/ID30351A/id unknown
- 2000-01-10 CA CA002359986A patent/CA2359986A1/en not_active Abandoned
- 2000-01-10 TR TR2001/02043T patent/TR200102043T2/xx unknown
- 2000-01-10 JP JP2000593621A patent/JP2002534530A/ja active Pending
- 2000-01-10 PT PT00900088T patent/PT1147119E/pt unknown
- 2000-01-10 HR HR20010529A patent/HRP20010529B1/xx not_active IP Right Cessation
- 2000-01-10 BR BR0007553-1A patent/BR0007553A/pt not_active IP Right Cessation
- 2000-01-10 DK DK00900088T patent/DK1147119T3/da active
- 2000-01-10 MX MXPA01007187A patent/MXPA01007187A/es not_active IP Right Cessation
- 2000-01-10 NZ NZ527483A patent/NZ527483A/en unknown
- 2000-01-10 NZ NZ512852A patent/NZ512852A/xx unknown
- 2000-01-10 YU YU50701A patent/YU50701A/sh unknown
- 2000-01-10 CZ CZ20012540A patent/CZ20012540A3/cs unknown
- 2000-01-10 DE DE60005300T patent/DE60005300T2/de not_active Expired - Fee Related
- 2000-01-10 EP EP00900088A patent/EP1147119B1/en not_active Expired - Lifetime
- 2000-01-10 AT AT00900088T patent/ATE250074T1/de not_active IP Right Cessation
- 2000-01-14 MY MYPI20000121A patent/MY121135A/en unknown
- 2000-01-14 PA PA20008489901A patent/PA8489901A1/es unknown
- 2000-01-14 CO CO00001575A patent/CO5180591A1/es not_active Application Discontinuation
-
2001
- 2001-07-12 CR CR6423A patent/CR6423A/xx not_active Application Discontinuation
- 2001-07-12 MA MA26266A patent/MA25342A1/fr unknown
- 2001-07-26 BG BG105745A patent/BG105745A/xx unknown
-
2003
- 2003-07-01 US US10/611,091 patent/US20040018995A1/en not_active Abandoned
- 2003-07-01 US US10/611,093 patent/US7005422B2/en not_active Expired - Fee Related
- 2003-07-01 US US10/610,719 patent/US7037899B2/en not_active Expired - Fee Related
- 2003-07-01 US US10/611,386 patent/US7005516B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0203183A3 (en) | Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use | |
| HUP0203142A3 (en) | Benzodiazepine derivatives, process for preparation of the compounds, pharmaceutical compositions containing them and their use | |
| HUP0200076A3 (en) | C-21 modified epothilones, process for their preparation, pharmaceutical compositions containing them | |
| HUP0203438A3 (en) | 5-(2-substituted-5-heterocyclysulphonylpyrid-3-yl)-dihydropyrazolo[4,3-d]pyrimidin-7-ones as phosphodiesterase inhibitors, process for their preparation and pharmaceutical compositions containing them | |
| HUP0103567A3 (en) | 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists, process for their preparation and pharmaceutical compositions containing the same | |
| HUP0003844A3 (en) | Novel spiroazabicyclic heterocyclic compounds, process for their preparation, their use and pharmaceutical compositions containing them | |
| HUP0204245A3 (en) | Novel n-azabicyclo-amide derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| HUP0401083A3 (en) | 4-amino-6-phenyl-pyrrolo [2,3-d] pyrimidine derivatives, pharmaceutical compositions containing them and process for the preparation of the compounds | |
| HUP0203107A3 (en) | Novel spiro compounds, process for their preparation and pharmaceutical compositions containing them | |
| HUP0105437A3 (en) | Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them | |
| HUP0204226A3 (en) | Quinazoline derivatives, pharmaceutical compositions containing them, their use and process for the preparation of the compounds | |
| HUP0200190A3 (en) | Dimeric compounds and as inhibitors of neuraminidase, process for their preparation and pharmaceutical compositions containing them | |
| HUP0202186A3 (en) | Benzimidazolone derivatives, process for their preparation, pharmaceutical compositions containing them and their use as phosphodiesterase inhibitors for producing pharmaceutical compositions | |
| HUP0201122A3 (en) | Pyrimidinone compounds, process for their preparation and pharmaceutical compositions containing them | |
| HUP0200881A3 (en) | Renin inhibitors, process for preparation of the compounds, pharmaceutical compositions containing them and their use | |
| HUP0202731A3 (en) | O-anisamide derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0105108A3 (en) | Amide compounds, process for their preparation and pharmaceutical compositions containing them | |
| HUP0201516A3 (en) | 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0201753A3 (en) | Pyridopyranoazepine derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0202075A3 (en) | Substituted 2-dialkylaminoalkylbiphenyl derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| HUP0203422A3 (en) | Imidazole derivatives as phosphodiesterase vii inhibitors, process for their preparation and pharmaceutical compositions containing them | |
| IL146104A0 (en) | Substituted bicyclic heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing the same | |
| HUP0200097A3 (en) | Derivatives of monosaccharides as cell adhesion inhibitors and pharmaceutical compositions containing them and process for their preparation | |
| HUP0200281A2 (en) | Heterocyclic benzenesulphonamide compounds as bradykinine antagonists, process for their preparation and pharmaceutical compositions containing them | |
| HUP0201730A3 (en) | Thienopyrimidines as phosphodiesterase inhibitors, their use, pharmaceutical compositions containing them and process for the preparation thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |